ProCE Banner Activity

Monoclonal Antibodies for COVID-19 Postexposure Prophylaxis

Multimedia
Hear expert insights on the rationale for the use of monoclonal antibodies for postexposure prophylaxis in high-risk populations.

Released: December 15, 2021

Expiration: December 14, 2022

No longer available for credit.

Share

Faculty

Arthur Kim

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD, has disclosed that he has served on the drug and safety monitoring board of Kintor Pharmaceuticals.